恶性肿瘤对院外心脏骤停患者长期生存的影响
本研究回顾性分析单中心6年内341例成人院外心脏骤停(OHCA)患者,其中59例(17.3%)合并恶性肿瘤,比较两组1年生存率及次要结局。结果显示两组持续自主循环恢复、入院生存、出院生存及出院时良好神经功能(CPC 1或2)均无差异,但恶性肿瘤组1年生存率显著更低(1.7% vs 11.4%,P=0.026)。Kaplan-Meier分析显示恶性肿瘤组在全体患者(n=341,P=0.028)、入院生存亚组(n=172,P=0.002)、出院CPC 1或2亚组(n=18,P=0.010)及出院CPC 3或4亚组(n=57,P=0.008)中1年生存率均显著更低。Cox回归显示恶性肿瘤是入院生存及出院生存患者1年死亡率的独立危险因素。
要点
- 合并恶性肿瘤的OHCA患者1年生存率仅1.7%,显著低于无恶性肿瘤者的11.4%(P=0.026)。
- 两组持续ROSC、入院生存率、出院生存率及出院良好神经功能(CPC 1或2)无显著差异。
- Kaplan-Meier分析显示恶性肿瘤组1年生存率在全体患者(n=341,P=0.028)及入院生存亚组(n=172,P=0.002)均显著更低。
- 出院CPC 1或2亚组(n=18,P=0.010)和CPC 3或4亚组(n=57,P=0.008)中,恶性肿瘤组1年生存率仍显著更低。
- Cox回归显示恶性肿瘤是入院生存及出院生存患者1年死亡率的独立危险因素。
适用人群与场景
- 成人院外心脏骤停(OHCA)患者,单中心回顾性分析6年数据,共341例,其中59例(17.3%)合并恶性肿瘤。
研究设计与关键结果
- 研究类型:单中心回顾性分析,纳入341例成人OHCA患者,合并恶性肿瘤者59例(17.3%)。
- 主要终点:1年生存率恶性肿瘤组1.7% vs 无恶性肿瘤组11.4%(P=0.026)。
- 次要终点:持续ROSC、入院生存、出院生存及出院良好神经功能(CPC 1或2)两组间无显著差异。
- Kaplan-Meier分析:全体患者(n=341)恶性肿瘤组1年生存率显著更低(P=0.028);入院生存亚组(n=172,P=0.002)、出院CPC 1或2亚组(n=18,P=0.010)、出院CPC 3或4亚组(n=57,P=0.008)中恶性肿瘤组1年生存率均显著更低。
- Cox比例风险回归:在入院生存及出院生存患者中,恶性肿瘤是1年死亡率的独立危险因素。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于合并恶性肿瘤的OHCA患者,应知晓其入院生存率、出院生存率及出院神经功能结局与无恶性肿瘤者无显著差异,但1年生存率显著更低(1.7% vs 11.4%)。
- 原文结论未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The aim of this study was to investigate whether the 1-year survival rate of out-of-hospital cardiac arrest (OHCA) patients with malignancy was different from that of those without malignancy.
METHODS: All adult OHCA patients were retrospectively analyzed in a single institution for 6years. The primary outcome was 1-year survival, and secondary outcomes were sustained return of spontaneous circulation (ROSC), survival to hospital admission, survival to discharge and discharge with a good neurological outcome (CPC 1 or 2). Kaplan-Meier survival analysis and Cox proportional hazard regression analysis were performed to test the effect of malignancy.
RESULTS: Among 341 OHCA patients, 59 patients had malignancy (17.3%). Sustained ROSC, survival to admission, survival to discharge and discharge with a good CPC were not different between the two groups. The 1-year survival rate was lower in patients with malignancy (1.7% vs 11.4%; P=0.026). Kaplan-Meier survival analysis revealed that patients with malignancy had a significantly lower 1-year survival rate when including all patients (n=341; P=0.028), patients with survival to admission (n=172, P=0.002), patients with discharge CPC 1 or 2 (n=18, P=0.010) and patients with discharge CPC 3 or 4 (n=57, P=0.008). Malignancy was an independent risk factor for 1-year mortality in the Cox proportional hazard regression analysis performed in patients with survival to admission and survival to discharge.
CONCLUSIONS: Although survival to admission, survival to discharge and discharge with a good CPC rate were not different, the 1-year survival rate was significantly lower in OHCA patients with malignancy than in those without malignancy.
参考来源
- Kang SB, Kim KS, Suh GJ, et al. Long-term survival of out-of-hospital cardiac arrest patients with malignancy. Am J Emerg Med. 2017. PMID: 28457761. doi:10.1016/j.ajem.2017.04.051
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。